Common use of Equity Warrants Clause in Contracts

Equity Warrants. The prospectus supplement relating to a particular series of warrants to purchase our common stock or preferred stock will describe the terms of the warrants, including the following: • the title of the warrants; • the offering price for the warrants, if any; • the aggregate number of warrants; • the designation and terms of the common stock or preferred stock that may be purchased upon exercise of the warrants; • if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each security; • if applicable, the date from and after which the warrants and any securities issued with the warrants will be separately transferable; • the number of shares of common stock or preferred stock that may be purchased upon exercise of a warrant and the exercise price for the warrants; • the dates on which the right to exercise the warrants shall commence and expire; • if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; • the currency or currency units in which the offering price, if any, and the exercise price are payable; • if applicable, a discussion of material U.S. federal income tax considerations; • the antidilution provisions of the warrants, if any; • the redemption or call provisions, if any, applicable to the warrants; • any provisions with respect to a holder’s right to require us to repurchase the warrants upon a change in control or similar event; and • any additional terms of the warrants, including procedures, and limitations relating to the exchange, exercise, and settlement of the warrants. Holders of equity warrants will not be entitled: • to vote, consent, or receive dividends; • receive notice as stockholders with respect to any meeting of stockholders for the election of our directors, or any other matter; or • exercise any rights as stockholders of Achieve.

Equity Warrants. The prospectus supplement relating to a particular series of warrants to purchase our common stock or preferred stock will describe the terms of the warrants, including the following: • ∎ the title of the warrants; • ∎ the offering price for the warrants, if any; • ∎ the aggregate number of warrants; • ∎ the designation and terms of the common stock or preferred stock that may be purchased upon exercise of the warrants; • ∎ if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each security; • ∎ if applicable, the date from and after which the warrants and any securities issued with the warrants will be separately transferable; • ∎ the number of shares of common stock or preferred stock that may be purchased upon exercise of a warrant and the exercise price for the warrants; • ∎ the dates on which the right to exercise the warrants shall commence and expire; • ∎ if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; • ∎ the currency or currency units in which the offering price, if any, and the exercise price are payable; • ∎ if applicable, a discussion of material U.S. federal income tax considerations; • ∎ the antidilution provisions of the warrants, if any; • ∎ the redemption or call provisions, if any, applicable to the warrants; • ∎ any provisions with respect to a holder’s right to require us to repurchase the warrants upon a change in control or similar event; and • ∎ any additional terms of the warrants, including procedures, procedures and limitations relating to the exchange, exercise, exercise and settlement of the warrants. Holders of equity warrants will not be entitled: • ∎ to vote, consent, or receive dividends; • ∎ receive notice as stockholders with respect to any meeting of stockholders for the election of our directors, directors or any other matter; or • ∎ exercise any rights as stockholders of Achievestockholders.

Equity Warrants. The prospectus supplement relating to a particular series of warrants to purchase our common stock or preferred stock will describe the terms of the warrants, including the following: • the title of the warrants; • the offering price for the warrants, if any; • the aggregate number of warrants; • the designation and terms of the common stock or preferred stock that may be purchased upon exercise of the warrants; • if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each security; • if applicable, the date from and after which the warrants and any securities issued with the warrants will be separately transferable; • the number of shares of common stock or preferred stock that may be purchased upon exercise of a warrant and the exercise price for the warrants; • the dates on which the right to exercise the warrants shall commence and expire; • if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; • the currency or currency units in which the offering price, if any, and the exercise price are payable; • if applicable, a discussion of material U.S. federal income tax considerations; • the antidilution provisions of the warrants, if any; • the redemption or call provisions, if any, applicable to the warrants; • any provisions with respect to a holder’s right to require us to repurchase the warrants upon a change in control or similar event; and • any additional terms of the warrants, including procedures, procedures and limitations relating to the exchange, exercise, exercise and settlement of the warrants. Holders of equity warrants will not be entitledentitled to: • to vote, consent, or receive dividends; • receive notice as stockholders with respect to any meeting of stockholders for the election of our directors, directors or any other matter; or • exercise any rights as stockholders of Achievestockholders.

Equity Warrants. The prospectus supplement relating to a particular series of warrants to purchase our common stock or preferred stock will describe the terms of the warrants, including the following: • the title of the warrants; • the offering price for the warrants, if any; • the aggregate number of warrants; • the designation and terms of the common stock or preferred stock that may be purchased upon exercise of the warrants; • if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each security; • if applicable, the date from and after which the warrants and any securities issued with the warrants will be separately transferable; • the number of shares of common stock or preferred stock that may be purchased upon exercise of a warrant and the exercise price for the warrants; • the dates on which the right to exercise the warrants shall commence and expire; • if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; • the currency or currency units in which the offering price, if any, and the exercise price are payable; • if applicable, a discussion of material U.S. federal income tax considerations; • the antidilution provisions of the warrants, if any; • the redemption or call provisions, if any, applicable to the warrants; • any provisions with respect to a holder’s right to require us to repurchase the warrants upon a change in control or similar event; and • any additional terms of the warrants, including procedures, procedures and limitations relating to the exchange, exercise, exercise and settlement of the warrants. Holders of equity warrants will not be entitled: • to vote, consent, or receive dividends; • receive notice as stockholders with respect to any meeting of stockholders for the election of our directors, directors or any other matter; or • exercise any rights as stockholders of Achievestockholders.

Equity Warrants. The prospectus supplement relating to a particular series of warrants to purchase our common stock or preferred stock will describe the terms of the warrants, including the following: • the title of the warrants; • the offering price for the warrants, if any; • the aggregate number of warrants; • the designation and terms of the common stock or preferred stock that may be purchased upon exercise of the warrants; • if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each security; • if applicable, the date from and after which the warrants and any securities issued with the warrants will be separately transferable; • the number of shares of common stock or preferred stock that may be purchased upon exercise of a warrant and the exercise price for the warrants; • the dates on which the right to exercise the warrants shall commence and expire; • if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; • the currency or currency units in which the offering price, if any, and the exercise price are payable; • if applicable, a discussion of material U.S. federal income tax considerations; • the antidilution provisions of the warrants, if any; • the redemption or call provisions, if any, applicable to the warrants; • any provisions with respect to a holder’s right to require us to repurchase the warrants upon a change in control or similar event; and • any additional terms of the warrants, including procedures, procedures and limitations relating to the exchange, exercise, exercise and settlement of the warrants. Holders of equity warrants will not be entitled: • to vote, consent, consent or receive dividends; • receive notice as stockholders with respect to any meeting of stockholders for the election of our directors, directors or any other matter; or • exercise any rights as stockholders of Achievestockholders.